Welcome to our dedicated page for Lifemd news (Ticker: LFMD), a resource for investors and traders seeking the latest updates and insights on Lifemd stock.
LifeMD, Inc. provides virtual primary care through a direct-to-patient telehealth platform that combines telemedicine, laboratory access, pharmacy services, a 50-state affiliated medical group, an affiliated pharmacy and a U.S.-based patient care center. Company news commonly covers its Telehealth operating segment, recurring subscription revenue, patient sign-ups, gross margin trends and guidance.
Recurring updates also address LifeMD’s specialized care areas, including primary care, men’s and women’s health, weight management and hormone therapy. News items feature GLP-1 weight management offerings such as Wegovy and Foundayo, branded therapy access through manufacturer programs, preferred stock dividends, executive leadership changes and investor conference participation.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
LifeMD, Inc. (NASDAQ: LFMD) has launched new membership plans aimed at enhancing access to virtual primary care services. The innovative features in the proprietary mobile app now allow consumers to download it for free, gain access to a symptom checker, a discounted prescription card, and a live appointment queue for immediate virtual consultations. The company is introducing three membership tiers: FlexCare, which requires no membership fee; TotalCare, a quarterly plan that includes monthly visits; and ConciergeCare, which offers unlimited visits with a dedicated doctor. The expansion of these services is anticipated to support ongoing membership growth and positions LifeMD favorably in the evolving telehealth market, expected to see significant disruption by 2030 according to Bain and Co.